FAC Explorer

Audit 299658

FY End
2023-06-30
Total Expended
$6.04M
Findings
0
Programs
10
Organization: San Diego Biomedical Research Institute (CA)
Year: 2023 Accepted: 2024-03-28
Auditor: Leaf & Cole LLP

Organization Exclusion Status:

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.859 Biomedical Research and Research Training $591,317 Yes 0
93.113 Environmental Health $566,471 Yes 0
93.393 Cancer Cause and Prevention Research $457,738 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $330,085 Yes 0
93.310 Trans-Nih Research Support $313,412 Yes 0
93.279 Drug Abuse and Addiction Research Programs $287,893 Yes 0
93.839 Blood Diseases and Resources Research $178,267 Yes 0
93.172 Human Genome Research $57,856 Yes 0
93.866 Aging Research $36,446 Yes 0
93.855 Allergy, Immunology and Transplantation Research $22,216 Yes 0

Contacts

Name Title Type
ZM3DYHAGMKM3 Christine Auciello Auditee
8582007086 Jill Branch Auditor
No contacts on file

Notes to SEFA

Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: N Rate Explanation: San Diego Biomedical Research Institute has elected not to use the 10-percent de minimis indirect cost rate as allowed under Uniform Guidance.